💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

UnitedHealth Continues Healthcare Shakeup With DaVita Deal

Published 12/06/2017, 01:03 AM
Updated 07/09/2023, 06:31 AM
AMZN
-
AET
-
CVS
-
UNH
-
DVA
-

On Wednesday, only a few days after the CVS (NYSE:CVS) and Aetna (NYSE:AET) deal helped shine a light on the quickly changing healthcare industry, UnitedHealth Group (NYSE:UNH) announced that it will buy a unit of DaVita Inc. (NYSE:DVA) for nearly $5 billion.

UnitedHealth, the country’s biggest health insurer, announced that its Optum division reached an agreement to acquire DaVita Medical Group for roughly $4.9 billion in cash. This deal, which is expected to close in 2018, is aimed to help expand UnitedHealth’s primary and urgent care services.

UnitedHealth hopes to pair DaVita Medical Group’s 300 medical clinics, 35 urgent-care centers, and six outpatient surgery centers—which reach around 1.7 million patients a year—with Optum’s massive insurance division.

“Combining DaVita Medical Group and Optum advances our shared goal of supporting physicians in delivering exceptional patient care in innovative and efficient ways while working with more than 300 health care payers across Optum in ways that better meet the needs of their members,” Optum CEO Larry C. Renfro said in a statement.

Optum also runs its own primary and urgent care centers, surgery centers, and senior and advanced care centers. Officials at both companies noted that the deal aims to help improve and streamline the ability to treat patients.

This move is part of a growing shift for health insurers to play a more direct role in actual medical services. Many health insurers now want to be able to provide their own patient care as often as possible. The deal will hopefully cut costs and improve care, given the proximity and number of care centers—especially for people with non-life threatening, chronic conditions.

The move comes after CVS announced its acquisition of healthcare benefits giant Aetna on Sunday. The $69 billion deal will allow the companies to offer more healthcare services at CVS stores.

UnitedHealth's latest deal is its second acquisition in 2017 aimed at bolstering its offerings beyond insurance. In March, UnitedHealth purchased Surgical Care Affiliates for $2.3 billion.

Shares of DaVita soared 12% premarket on the back of the announcement. Since then, the stock has cooled a bit and now hovers up around 10% at $67.20 per share, which is still $3 below its 52-week high.

UnitedHealth saw its stock price dip in early morning trading, but shares have since gained around 0.80%. CVS stock dipped slightly on Wednesday following the UnitedHealth and DaVita deal.

Wall Street’s Next Amazon (NASDAQ:AMZN)

Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.

Click for details >>



Aetna Inc. (AET): Free Stock Analysis Report

UnitedHealth Group Incorporated (UNH): Free Stock Analysis Report

DaVita HealthCare Partners Inc. (DVA): Free Stock Analysis Report

CVS Health Corporation (CVS): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.